Under the deal, IOI Properties will buy CDL’s 50.1% stake in South Beach in a deal valuing the property at S$2.75 billion ($2 ...

Despite the rise in insurance costs, overall price pressures remain contained. Singapore’s 13.3% year-on-year rise in health ...

Core consumer prices increased by 0.5% MoM, reversing the previous month's decline, whilst the YoY figure edged up to 0.7%.

Buying insurance is one way of protecting ourselves against the financial risk that comes with getting ill or getting an accident.

Over the next review cycle, the increase in premiums will amount to S$1.8bn and changes to the deductibles will reduce MediShield Life payouts by S$0.6bn. Earlier in October this year, the Singapore ...

SINGAPORE: MediShield Life coverage is set to expand with parliament passing a law on Monday (Nov 11) to include new models of care received outside the physical premises of healthcare providers ...

SINGAPORE (The Straits Times/ANN): A package of S$4.1 billion (RM13.17 billion) in support measures will be provided to Singaporeans to cushion the increases in premiums for MediShield Life ...

SINGAPORE: MediShield Life premiums will increase from April 2025 as the government expands the national health insurance scheme. This comes after a review of the insurance scheme by the ...

MEDISHIELD Life, introduced in 2015, is Singapore’s national health insurance scheme. It provides universal, lifelong coverage to help citizens and permanent residents manage large hospital bills and ...

Launched in 2015, MediShield Life is Singapore’s national insurance scheme, providing basic protection against large medical bills. Here are some of the common questions about the scheme.

Complain about how expensive healthcare is in Singapore? Well, after doing that, the next thing you should do is to see how MediShield Life can help you. But what is MediShield Life anyway?

Singapore is currently paying higher prices for cancer drugs compared to other regional countries such as Taiwan, South Korea, Australia and New Zealand. Drug manufactures are not incentivised to ...